ISO/IEC 17025 is the international standard for the competence of testing and calibration laboratories. A peptide certificate of analysis (COA) issued by a laboratory accredited to it, within the scope of the methods actually accredited, carries considerably more evidential weight than an in-house or unaccredited result. In Australia, that accreditation is granted by NATA, and the phrase "ISO 17025 tested" is only as meaningful as the scope behind it. This article sets out what the standard certifies, what it does not, how to verify a claim, and how the result should be read alongside Australian regulatory realities.
What ISO/IEC 17025 certifies
The standard, published as ISO/IEC 17025:2017, specifies general requirements for the competence, impartiality and consistent operation of testing and calibration laboratories. Accreditation is not a product approval and not an endorsement of the material tested. It is an independent assessment of the laboratory: its documented management system, its personnel, its equipment, and its technical ability to perform defined tests and report valid results.
According to NATA, accreditation supports the validity and reliability of results across many industry sectors, and its principal value lies less in owning instruments than in the consistency of the processes around them: sample receipt and handling, method validation, and data reporting. That process discipline is what allows data to be accepted internationally.
For peptide work, four practical consequences follow:
- Traceability of the sample. A chain from receipt to report reduces the probability of mislabelled or swapped vials.
- Validated methods. The purity method (typically reversed-phase HPLC with UV detection) has documented performance characteristics rather than ad hoc settings.
- Controlled reporting. Reports follow defined content requirements, and amendments are recorded.
- Impartiality. The laboratory is obliged to manage conflicts of interest, which is the central reason a supplier's own bench result and an independent laboratory's result are not equivalent evidence.
Accreditation is site-specific and method-specific
The most common misreading of the term is to treat it as a blanket property of a company. It is not. Accreditation attaches to a specific site and to a defined scope of tests. A laboratory may hold accreditation for LC-MS of purified proteins, for example, and hold none for endotoxin or sterility testing, or for the compound class under examination. The NATA register entry for the Australian Proteome Analysis Facility (site number 24323) illustrates this: the listing identifies particular techniques and analyte categories, and users are expected to confirm that their required method falls inside it.
Before relying on a certificate, the following questions should be answered from the accreditation body's register rather than from the laboratory's marketing page:
- Is the laboratory's site listed with the accreditation body, and is the accreditation current?
- Does the scope include the technique used (HPLC purity, LC-MS identity, amino acid analysis, endotoxin, sterility)?
- Does the scope cover the analyte class (peptides, as opposed to small molecules or food matrices)?
- Does the report carry the accreditation body's endorsement or logo only on the tests that are actually within scope? Reports commonly mix accredited and non-accredited results.
- Is the accreditation body itself a signatory to the international mutual recognition arrangements? NATA is the primary Australian body, and others, such as ALAB, also assess laboratories against ISO/IEC 17025:2017.
Which tests a peptide quality panel contains
No single assay establishes the quality of a peptide. A defensible panel combines orthogonal measurements, each answering a different question.
| Test | Question answered | Typical technique |
|---|---|---|
| Purity | What fraction of the chromatographic signal is the target peptide? | RP-HPLC with UV detection |
| Identity | Does the molecular mass match the expected sequence? | Mass spectrometry (MALDI-TOF or LC-MS) |
| Content (net peptide) | How much peptide, as opposed to water and counter-ions, is in the vial? | Amino acid analysis or quantitative methods |
| Endotoxin | Are bacterial pyrogens within limits? | LAL-based assays |
| Sterility | Is the material free of viable microorganisms? | Compendial culture methods |
| Residual contaminants | Heavy metals, residual solvents | ICP-MS, GC |
The distinction between purity and content is routinely lost in supplier marketing. A figure of 99% by HPLC indicates the proportion of the peptide-related chromatographic signal attributable to the main peak. It says nothing on its own about how many milligrams of peptide a vial contains, nor about endotoxin or sterility. For a detailed account of the mass-spectrometric component, see our practical guide to mass spec peptide verification, and for the microbiological side, the sterility testing checklist for lab release.
Accredited testing in Australia
NATA-accredited facilities with peptide-relevant scopes exist domestically, including the Australian Proteome Analysis Facility noted above. Researchers and pharmaceutical firms use such facilities for identity, purity and concentration analysis by HPLC and LC-MS/MS. Where an Australian laboratory does not cover a given method, overseas laboratories accredited under the same international framework are an alternative, though the same scope check applies, and so does the import requirement for shipping samples.
Sample logistics matter for cost and timing. One laboratory's published guidance indicates that around 10 mg of material is typically the minimum for a full QC panel, and that several vials, commonly three or more, are preferred so material can be divided across HPLC, endotoxin and sterility work. Requirements differ between laboratories, so the submission guide of the chosen facility governs.
Reading a certificate of analysis
A COA is a document, and documents vary in quality. A certificate suited to supporting a research decision generally shows the following:
- The name and address of the testing laboratory, distinct from the supplier.
- A batch or lot number that matches the number printed on the vial.
- The test date, the method, and the instrument used.
- The chromatogram itself, not only a summary percentage, so peak integration and impurity profile can be inspected.
- The mass spectrum, with observed and theoretical molecular mass.
- Clear marking of which results fall within the laboratory's accredited scope.
- A signature or authorisation by a named reviewer.
Red flags include a certificate with no lot number, a round purity value with no chromatogram, a laboratory with no verifiable accreditation entry, and a report issued by the seller's own affiliate. A walkthrough of lot-level verification, written for the regulatory context, is available in this explanation of reading a lot-specific COA, and our own checklist of laboratory checks for spotting counterfeit peptides expands on batch-matching and document forensics.
Why verification matters in the Australian market
The case for independent, accredited analysis is not abstract. Reporting on testing of unapproved peptide products in Australia described dose variability from 40% to 190% of the labelled amount, and purity as low as 16.6%, with the remainder consisting of fillers and unidentified contaminants. The same report described seven people in Victoria hospitalised with acute liver toxicity after injecting counterfeit peptides purchased outside the medical system.
The Therapeutic Goods Administration has also issued a safety alert on unregulated peptides, reported in April 2026, and states that it is monitoring the issue from both safety and law enforcement perspectives.
Two points follow for any reader evaluating testing claims:
- Accredited analysis addresses analytical truthfulness (what is in the vial), not legality or suitability for any use.
- Analytical quality is the minimum condition for credible research, since an unverified material invalidates downstream experimental data regardless of the quality of the protocol.
Regulatory position: research labelling is not an exemption
The regulatory context must be stated plainly. According to University of Sydney commentary, peptides such as BPC-157, CJC-1295 and TB-500 are not approved, and the same analysis notes that Australian law does not treat a "research use only" label as an exemption where a product is in substance a therapeutic good intended for human use. Supply or advertising of such goods without TGA approval is unlawful in that circumstance.
An ISO/IEC 17025 certificate therefore does not convert a product into an approved medicine. It documents analytical properties of a batch. Persons who are not conducting laboratory research should not interpret any COA as evidence of safety or efficacy in humans. Those with health questions should consult a registered medical practitioner. For a fuller treatment, see our overview of whether peptides are legal in Australia.
Perspective: how we approach verification
Au Peptide Labs supplies research peptides strictly for laboratory use, and all products are stocked and dispatched from Australia. Our stated standard is independent third-party testing to 99%+ purity with a verifiable COA for every batch. We consider that standard meaningful only to the extent that a purchaser can audit it, which is why we encourage researchers to match the lot number on the vial to the certificate, to inspect the chromatogram and mass spectrum rather than the headline percentage, and to check the issuing laboratory's accreditation entry and scope for the specific method reported.
We also hold that accreditation language is frequently over-read. A laboratory being accredited does not mean every number on a report was generated under accreditation, and it does not speak to the lawful use of the material. Our products are not for human or veterinary use, and we do not suggest otherwise. Our own overview of third-party testing for peptides in Australia describes the audit steps we recommend to purchasers, and we welcome scrutiny of them.
— Dr. Authur
Sourcing materials with documented testing
Research groups that wish to reduce the verification burden can source domestically from a supplier that publishes batch COAs and ships within Australia, avoiding customs holds that can compromise cold-chain integrity. Au Peptide Labs dispatches from Melbourne, and Express Post is listed at $10 one-off. Catalogue categories include Metabolic & GLP-1, Recovery & Repair and Lab Supplies, and the full range is available from the Au Peptide Labs store. Custom and bulk orders are available on request. Before ordering from any supplier, our checklist on what to verify before ordering locally is a sensible reference. Cold-chain handling after receipt is covered in our note on validating peptide cold chain in the laboratory.
FAQ
What does "ISO 17025 lab tested" mean?
It means the testing was carried out by a laboratory that an accreditation body has assessed against ISO/IEC 17025 for competence and consistent operation. The claim is only reliable if the specific method used appears in that laboratory's current scope. Ask for the accreditation number and check it on the accreditation body's register.
Where can a laboratory in Australia test peptides?
NATA's register lists accredited organisations, and facilities such as the Australian Proteome Analysis Facility hold accreditation for relevant techniques. Scopes differ, so confirm that HPLC purity, mass spectrometry identity or any other required test is covered. Contact the laboratory for its sample volume and submission requirements.
Is a 99% purity figure enough to trust a peptide?
No. Purity by HPLC describes the share of the chromatographic signal belonging to the main peak. Identity by mass spectrometry, net peptide content, endotoxin and sterility are separate questions, and a credible COA should show the underlying chromatogram and spectrum for the lot in hand.
Does an accredited COA make a peptide legal to use in people?
No. A COA documents analytical properties of a batch and has no bearing on TGA approval. Peptides sold for human use without approval remain unlawful to supply, and anyone with health concerns should speak to a registered medical practitioner.
Sources
- NATA: Testing & Calibration (ISO/IEC 17025) Accreditation
- ISO/IEC 17025:2017 standard page
- NATA register: Australian Proteome Analysis Facility
- ALAB: Accreditation against ISO/IEC 17025
- ILS Laboratories: Peptide testing services
- Pink Times: Australia warns over counterfeit peptides after Victoria hospitalisations
- ABC News: TGA issues safety alert on illegal peptide use
- University of Sydney: How wellness clinics bend the rules to supply unapproved peptides